Two-drug regimen for HIV
The Lancet in conversation with - Un pódcast de The Lancet Group - Viernes
Categorías:
Jessamy Bagenal and Kimberly Smith discuss implications arising from the Gemini study, which shows how a two-drug combination is not inferior to a conventional three-drug regimen in the treatment of HIV.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
